Effectively Quantify & Measure the Success of Patient Engagement Activities to Better Meet Regulatory Requirement, Prove ROI to Key Stakeholders & Ultimately Improve the Patient Experience
Patient engagement is no longer optional - it’s a strategic imperative.
Regulators expect defensible evidence, executives demand clear ROI, and tighter funding and portfolio scrutiny mean every engagement activity must demonstrate real value. Yet across the industry, organizations still struggle to prove the impact of their efforts.
The 3rd Measuring Patient Engagement Summit is the only forum entirely focused on turning patient engagement strategies into measurable, credible impact. Over three days, 70+ senior leaders from pharma, biotech, and patient advocacy will convene to explore frameworks, tools, and practical approaches that show how patient input drives outcomes across development, access, and commercialization.
Through immersive workshops, hands-on case studies, and collaborative discussions, you will:
- Move beyond anecdotal reporting to defensible, outcome-based evidence
- Benchmark strategies, co-create frameworks, and track patient impact across multi-year programs
- Translate engagement into measurable influence for regulators, executives, and patient communities
- Leave equipped with peer-tested approaches, practical frameworks, and actionable insights to elevate your patient engagement from activity to strategic, measurable value
Measuring activity is no longer enough - demonstrating impact is what moves the industry forward.
The quality of the speakers was excellent. The format of each day also maximized the opportunity to network and share best practices in a coordinated and purposeful way.
Michele Barber, Associate Director, Patient Engagement, Mural Oncology
Everyone was incredibly open, transparent, and willing to share experiences. The information was new, fresh, and not presented before!
Marie Eckerd, Director, Patient Engagement, AstraZeneca
The topic is highly relevant, and the speakers brought new, actionable information to the group in attendance.
Tiffany Patrick, Chief Patient Officer, Alnylam Pharmaceuticals
Explore the Full Event Guide
- 15+ Real-world case studies revealing how patient engagement impact is being measured today
- Practical KPI frameworks you can apply across advocacy, development, access, and commercialization
- Clear strategies to prove ROI and secure sustained C-suite and portfolio buy-in
- Dedicated insights for rare disease and biotech teams operating with lean resources
- Peer benchmarking with 70+ senior leaders shaping the future of patient engagement evidence
Official Partners
Attending Companies Include
Explore Related Events
Explore the Agenda
Dive into case studies, practical workshops, and expert panels to uncover how leaders are proving the value of patient engagement.
Partner With Us
Showcase your solutions to senior pharma and biotech teams driving patient-centered strategies.
Join Biopharma Experts
Connect with peers and innovators across engagement, advocacy, clinical development, and medical affairs to share insights and build meaningful collaborations.